Biberach an der Riss, Germany

Ferenc Kontes

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.8

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ferenc Kontes: Innovator in Pharmaceutical Chemistry

Introduction

Ferenc Kontes is a notable inventor based in Biberach an der Riss, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for medical applications. With a total of two patents to his name, Kontes is recognized for his innovative approach to drug design.

Latest Patents

Kontes' latest patents focus on cyclopentathiophene carboxamide derivatives as platelet activating factor receptor antagonists. The first patent describes cyclopentathiophene carboxamides of a specific formula, which can be utilized in methods for treating diseases influenced by antagonizing the activity mediated by the platelet activating factor receptor. The second patent also relates to cyclopentathiophene carboxamides, emphasizing their potential use in similar therapeutic applications.

Career Highlights

Ferenc Kontes is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His work at the company has allowed him to collaborate with other talented professionals in the field, enhancing the development of innovative therapeutic solutions.

Collaborations

Some of Kontes' notable coworkers include Matthias Eckhardt and Christofer Siegfried Tautermann. Their collaborative efforts contribute to the advancement of research and development in pharmaceutical sciences.

Conclusion

Ferenc Kontes is a distinguished inventor whose work in pharmaceutical chemistry has the potential to impact the treatment of various diseases. His innovative patents and collaborations reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…